Liquor distributor D’Aquino Bros has been taken to court again, accused for the fourth time of “flagrant” trade mark infringement for continuing to sell products under the name, Scotch Whisky.
The World Intellectual Property Organisation has found bookmaker CrownBet was the “controlling mind” behind the cybersquatting of four domains that allegedly violated rival Betstar’s trade marks.
International airline Air New Zealand has been hit with a $15 million penalty for participating in a global air cargo cartel to fix the price of fuel, insurance and security surcharges.
Generic pharmaceutical company Aspen Pharma has resolved a patent infringement case brought by the maker of the anti-depressant Lexapro, according to a Federal Court order Tuesday.
A judge has granted F. Hoffman La-Roche’s request for a temporary order blocking Sandoz from making or selling a biosimilar version of its patented biologic used to treat various cancers and rheumatoid arthritis.
A judge has ordered mediation in the Brisbane floods class action, in which the victims of the 2011 disaster are seeking up to $1 billion in compensation.
As the ACCC’s criminal cartel case against ANZ, Citigroup and Deutsche Bank gets underway, the regulator will face off against a formidable team of lawyers with extensive experience in defending competition matters.
Three generic drug manufacturers cannot claim damages for an injunction barring the release of cheaper versions of Effexor-XR, even if the injunction was later overturned, pharmaceutical giant Wyeth told a judge on day two of a six-week trial over its blockbuster antidepressant.
Pharmaceutical giant Wyeth’s has launched an “ambush” at the beginning of a trial after a nine-year long battle against several generic drug makers, alleging infringement of a second patent for its blockbuster Effexor-XR, a judge heard Monday.
A decade-long courtroom battle over a patent for Effexor-XR that delayed the release of cheap versions of the anti-depressant is at the centre of a trial starting Monday in Sydney pitting four generic drug makers against pharmaceutical giant Wyeth.